New Key Statistics Module, Z-Score and F-Score
NAS:SVA Key Ratios
Market Cap $ M | 460.25 |
Enterprise Value $ M | -6,931.95 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.05 |
Price/Sales | 1.50 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 5.43 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 429.00 |
EPS (TTM) $ | -1.31 |
Beneish M-Score | -2.2 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 46.07 |
EV-to-EBITDA | 337.72 |
PEG | -- |
Shares Outstanding M | 71.86 |
Net Margin (%) | -29.06 |
Operating Margin % | -84.35 |
Pre-tax Margin (%) | -36.03 |
Quick Ratio | 11.24 |
Current Ratio | 11.39 |
ROA % (ttm) | -0.93 |
ROE % (ttm) | -1.44 |
ROIC % (ttm) | -34.45 |
Dividend Yield % | -- |
Altman Z-Score | 1.83 |
SVA Number of Guru Trades
SVA Volume of Guru Trades
Gurus Latest Trades with NAS:SVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SVA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sinovac Biotech Ltd Insider Transactions
No Available Data
News about NAS:SVA
Total 0- 1